Placental Tissue + Standard Care for Venous Leg Ulcers

(EVOLVE Trial)

BF
CR
Overseen ByCellution Research
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Cellution Biologics
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to determine how well our dHPT (Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of venous leg ulcers.

Who Is on the Research Team?

RD

Research Director

Principal Investigator

Cellution Biologics

Are You a Good Fit for This Trial?

This trial is for adults 18 or older with a venous leg ulcer that hasn't healed after at least 4 weeks of standard care. The ulcer must be between 0.7 and 20 cm² in size, and participants need to meet certain blood flow and health criteria.

Inclusion Criteria

I am 18 years old or older.
My ankle-brachial index (ABI) is between 0.7 and 1.3.
My ulcers are at least 2 cm apart after cleaning.
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • Dehydrated Human Placenta Tissue (dHPT)

Trial Overview

The study compares the effectiveness of treating venous leg ulcers using standard wound care alone versus standard care plus dehydrated human placental tissue (dHPT). Some patients may switch treatments during the study.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: AIC and Standard of CareExperimental Treatment2 Interventions
Group II: Standard of CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Cellution Biologics

Lead Sponsor

Trials
1
Recruited
290+